Labcorp: The CMS Selloff Represents An Excellent Opportunity - Strong Buy
Labcorp Holdings Inc LH
$309.64
▲ +0.22%
(+$0.69)
Index member:
S&P 500
⬆️ Above Yest. High
Open
$308.24
Prev Close
$308.95
Day Range
$306.55 – $312.30
52W Range
$244.52 – $341.80
Market Cap
$26.17B
P/E (TTM)
24.88
Beta
0.89
Div Yield
1.35%
EPS (TTM)
$12.09
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1991-04-24 |
| Shares Out. | 82,000,000 |
| Website | labcorp.com/ ↗ |
| Phone | 13362291127 |
| Employees | 71,000 |
| Revenue | $3.73B |
| Gross Profit | $1.11B |
| Net Income | $299.1M |
| Free Cash Flow | $1.16B |
| Total Assets | $18.53B |
| Total Liabilities | $9.91B |
| Equity | $8.62B |
About Labcorp Holdings Inc
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
Labcorp Holdings Inc is a publicly traded company under the ticker symbol LH on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
27 analysts (2026-09-01)
📰 Latest News for LH
Labcorp Holdings (LH) Eyes Acquisitions And Lab Tech Investment After 2026 Investor Day
2 Small-Cap Stocks to Research Further and 1 Facing Challenges
Is Labcorp Holdings Stock Outperforming the Dow?
Labcorp's Future Driven By Clinical Testing Demand, Despite Impact From Medicare Cuts
Stock Market Today: Dow Skids As Trump Threatens Iran; Medical Diagnostics Plays Swoon (Live Coverage)
Labcorp Reaffirms 2026–2029 Long-Term Outlook Following CMS Preliminary Medicare Payment Rate Release; Expects Compound Annual Adj EPS Growth Of 8.5%-11.5% In 2026-2029
Why Labcorp Holdings Stock Dropped Today

